Results 221 to 230 of about 18,378,232 (237)

β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial [PDF]

open access: yesLancet, The, 2019
BACKGROUND Clinical decompensation of cirrhosis is associated with poor prognosis. Clinically significant portal hypertension (CSPH), defined by a hepatic venous pressure gradient (HVPG) ≥10 mm Hg, is the strongest predictor of decompensation.
Rosa Maria Morillas   +2 more
exaly   +2 more sources

Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension

Liver International, 2023
Martin Lenicek   +2 more
exaly  

Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertension

Journal of Hepatology, 2015
Fanny Turon   +2 more
exaly  

Home - About - Disclaimer - Privacy